Bio-Techne TECH Income Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $311.42M-1.5% | $295.88M-0.4% | $286.56M-1.0% | $316.96M+3.5% | $316.18M+4.2% | ||
| $103.13M+1.5% | $104.6M+1.4% | $98.44M-7.5% | $118.15M+15.0% | $101.63M+2.8% | ||
| $208.29M-2.9% | $191.28M-1.3% | $188.11M+2.8% | $198.81M-2.2% | $214.56M+4.9% | ||
| 66.9%-1.0pp | 64.6%-0.6pp | 65.6%+2.4pp | 62.7%-3.7pp | 67.9%+0.4pp | ||
| $23.46M-4.6% | $23.13M-7.6% | $24.24M+1.6% | $26.03M+8.5% | $24.58M-4.6% | ||
| $109.34M-27.7% | $113.69M-6.4% | $116.21M-2.5% | $196.64M+47.3% | $151.27M+35.3% | ||
| $132.79M-24.5% | $136.82M-6.6% | $140.45M-1.8% | $222.67M+41.4% | $175.85M+27.8% | ||
| $132.79M-24.5% | $136.82M-6.6% | $140.45M-1.8% | $222.67M+41.4% | $175.85M+27.8% | ||
| $75.5M+95.0% | $54.46M+14.9% | $47.66M+19.2% | —— | $38.71M-42.2% | ||
| 24.2%+12.0pp | 18.4%+2.4pp | 16.6%+2.8pp | —— | 12.2%-9.8pp | ||
| —— | —— | —— | $2.13M-45.9% | $2.13M-45.9% | ||
| —— | —— | —— | $971.5K+16.9% | $971.5K+16.9% | ||
| -$4.27M-884% | -$3.68M+19.1% | $333K+81.0% | —— | -$434K+92.7% | ||
| $71.23M+86.1% | $50.78M+18.4% | $47.99M+19.5% | —— | $38.27M-37.3% | ||
| $20.18M+28.6% | $12.78M+60.0% | $9.81M+49.2% | —— | $15.69M+30.4% | ||
| $51.05M+126% | $38.01M+8.9% | $38.19M+13.6% | —— | $22.59M-54.0% | ||
| 16.4%+9.2pp | 12.8%+1.1pp | 13.3%+1.7pp | —— | 7.1%-9.0pp | ||
| $0.32+129% | $0.24+9.1% | $0.24+14.3% | —— | $0.14-54.8% | ||
| $0.33+136% | $0.24+9.1% | $0.25+19.0% | —— | $0.14-54.8% | ||
| 157.4M-1.0% | 157M-2.3% | 156.4M-3.0% | 159.7M-0.7% | 158.9M-1.0% | ||
| 156.3M-0.7% | 155.8M-1.6% | 155.5M-1.9% | 157.5M-0.1% | 157.4M0.0% | ||
| —— | —— | —— | $971.5K+16.9% | $971.5K+16.9% | ||
| $46.54M+77.7% | $40.06M+330% | $33.67M-35.0% | $4.49M-88.0% | $26.19M-30.0% | ||
| -$160K+90.7% | -$711K-1,480% | -$1.67M+45.0% | -$781K+27.3% | -$1.71M-611% | ||
| -$4.51M-225% | $2.05M+108% | -$4.52M-125% | $22.17M+837% | $3.6M+131% | ||
| —— | —— | —— | $207.75K+110% | $207.75K+110% | ||
| $23.46M-4.6% | $23.13M-7.6% | $24.24M+1.6% | $26.03M+8.5% | $24.58M-4.6% | ||
| $311.42M-1.5% | $295.88M-0.4% | $286.56M-1.0% | $316.96M+3.5% | $316.18M+4.2% | ||
| $75.5M+95.0% | $54.46M+14.9% | $47.66M+19.2% | —— | $38.71M-42.2% | ||
| $99.66M+50.4% | $79.17M+6.3% | $72M+5.7% | —— | $66.28M-29.7% | ||
| $99.66M+50.4% | $79.17M+6.3% | $72M+5.7% | —— | $66.28M-29.7% | ||
| 32%+11.0pp | 26.8%+1.7pp | 25.1%+1.6pp | —— | 21%-10.1pp | ||
| $75.5M+95.0% | $54.46M+14.9% | $47.66M+19.2% | —— | $38.71M-42.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Bio-Techne's revenue?
- Bio-Techne (TECH) generated $1.2B in revenue over the trailing twelve months, up 0.2% year over year.
- Is Bio-Techne profitable?
- Bio-Techne reported $149.8M in net income over the trailing twelve months, a 10.9% net margin.
- What are Bio-Techne's profit margins?
- Gross margin is 65.0% and operating margin is 14.2%, with a 10.9% net margin.
- What is Bio-Techne's earnings per share?
- Bio-Techne's diluted EPS over the trailing twelve months is $0.94.
- Where does Bio-Techne's income statement data come from?
- Every line is extracted from Bio-Techne's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
